What is the most common cause for Squamous cell carcinoma at the base of the tongue?

Explanation

## Correct Answer: A. HPV Squamous cell carcinoma (SCC) of the base of the tongue is most commonly associated with **HPV infection**, particularly HPV-16 and HPV-18 (high-risk types). The base of the tongue, being part of the oropharynx, has a specialized epithelium rich in lymphoid tissue (Waldeyer's ring) that is particularly susceptible to HPV-mediated malignant transformation. HPV-positive oropharyngeal cancers represent a distinct epidemiological and molecular entity from tobacco/alcohol-related SCCs. In India, the incidence of HPV-related oropharyngeal cancer is rising, especially in younger populations without traditional risk factors (smoking/alcohol). The virus integrates into the host genome, disrupting p53 and Rb pathways, leading to uncontrolled proliferation. HPV-positive oropharyngeal SCCs have a better prognosis and different treatment response compared to HPV-negative tumors, making HPV status a critical prognostic and therapeutic marker. The WHO classifies HPV-positive oropharyngeal SCC as a distinct entity, and HPV vaccination (Gardasil, Cervarix) is now recommended in India for prevention, particularly in adolescents. ## Why the other options are wrong **B. EBV** — EBV is associated with nasopharyngeal carcinoma (particularly in endemic areas like Southeast Asia and Southern China), not oropharyngeal SCC at the base of tongue. While EBV can be detected in some oropharyngeal cancers, it is NOT the primary etiological agent. This is a common trap—students confuse EBV's role in nasopharyngeal cancer with oropharyngeal sites. **C. HCV** — HCV is primarily associated with hepatocellular carcinoma and lymphomas, not oropharyngeal SCC. While HCV can cause oral lichen planus and potentially increase oral cancer risk indirectly, it is NOT a recognized major etiological agent for base-of-tongue SCC. This option exploits confusion between HCV's hepatic and systemic effects. **D. CMV** — CMV is an opportunistic pathogen in immunocompromised patients (HIV/AIDS) and can cause esophageal ulcers and colitis, but has NO established role in oropharyngeal SCC etiology. CMV is rarely implicated in malignant transformation of oropharyngeal epithelium. This is a distractor exploiting knowledge of CMV's oral manifestations in immunosuppression. ## High-Yield Facts - **HPV-16 and HPV-18** are the high-risk types responsible for ~90% of HPV-positive oropharyngeal cancers globally and increasingly in India. - **Base of tongue SCC** is now more commonly HPV-positive than tobacco/alcohol-related in developed nations; this trend is emerging in urban India. - **HPV-positive oropharyngeal SCC** has better 5-year survival (~70–80%) compared to HPV-negative tumors (~40–50%), influencing treatment de-escalation strategies. - **p53 and Rb inactivation** via HPV E6/E7 oncoproteins is the molecular mechanism driving malignant transformation in oropharyngeal epithelium. - **HPV vaccination** (quadrivalent/nonavalent) is now recommended in India for adolescents and young adults to prevent HPV-related oropharyngeal cancers. ## Mnemonics **OPharyngeal SCC Viruses** **HPV** (Oropharynx) vs **EBV** (Nasopharynx) — Remember: HPV = **H**igh-risk for **O**ropharynx; EBV = **E**ndemic in **N**asopharynx (Southeast Asia). Base of tongue = oropharynx = HPV. **Viral Oncogenesis Sites** **H**PV → Oropharynx/Cervix; **E**BV → Nasopharynx/Burkitt; **H**CV → Liver; **C**MV → Opportunistic (not malignant). Use first letter to anchor organ. ## NBE Trap NBE pairs EBV with oropharyngeal cancer to exploit students' knowledge of EBV-associated nasopharyngeal carcinoma. The trap: conflating anatomical sites (nasopharynx vs. oropharynx) and their distinct viral etiologies. ## Clinical Pearl In Indian clinical practice, a young patient (30–50 years) presenting with base-of-tongue SCC without significant smoking/alcohol history should raise suspicion for HPV-positive disease. HPV status now guides treatment intensity: HPV-positive patients may benefit from de-escalated chemotherapy or radiation protocols, reducing long-term morbidity while maintaining cure rates. _Reference: Robbins Ch. 6 (Neoplasia); Harrison Ch. 87 (Head & Neck Cancers); Park's Textbook of Preventive & Social Medicine (HPV epidemiology in India)_